Notably, the patient-derived AML samples harboring mutant NPM1 and FLT3-ITD fusions were more sensitive to GAB2 depletion than normal human CD34+ HSPCs from cord blood. The gene discussed is FLT3; the disease is acute myeloid leukemia.